Unclassified renal cell carcinoma: a report of 56 cases
Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Unclassified RCC represents 0.7–5.7% of renal tumours. Limited reported data from two series suggests that unclassified RCC is an aggressive form of RCC, mainly because most cases ar...
        Saved in:
      
    
          | Published in | BJU international Vol. 110; no. 6; pp. 786 - 793 | 
|---|---|
| Main Authors | , , , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        Oxford, UK
          Blackwell Publishing Ltd
    
        01.09.2012
     Wiley-Blackwell Wiley Subscription Services, Inc  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1464-4096 1464-410X 1464-410X  | 
| DOI | 10.1111/j.1464-410X.2012.10934.x | 
Cover
| Abstract | Study Type – Therapy (case series)
Level of Evidence 4
What's known on the subject? and What does the study add?
Unclassified RCC represents 0.7–5.7% of renal tumours. Limited reported data from two series suggests that unclassified RCC is an aggressive form of RCC, mainly because most cases are at an advanced stage at presentation, but overall and cancer‐specific survival were not significantly different between unclassified and clear‐cell RCC in an additional series of 38 patients.
Our study of 56 cases of unclassified RCC describes the pathological features that can be applied to predict prognosis on a daily basis. In particular nuclear grade, TNM classification, tumour coagulative necrosis, tumour size, microvascular invasion and 2004 WHO histotype are independent predictors of disease‐free and cancer‐specific survival.
OBJECTIVE
• 
To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria.
PATIENTS AND METHODS
• 
Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved.
• 
Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron‐sparing specimens.
• 
Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis.
RESULTS
• 
Fifty‐six cases met the histological criteria for unclassified RCC. Thirty‐four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements.
• 
Cox multivariate analysis showed nuclear grade (P= 0.020), stage (P < 0.001), tumour coagulative necrosis (P= 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P= 0.028) to be independent predictors of disease‐free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231–25.453).
• 
Nuclear grade (P= 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P= 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P= 0.056) were independent predictors of cancer‐specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329–40.622).
CONCLUSION
• 
The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC. | 
    
|---|---|
| AbstractList | What's known on the subject? and What does the study add? Unclassified RCC represents 0.7-5.7% of renal tumours. Limited reported data from two series suggests that unclassified RCC is an aggressive form of RCC, mainly because most cases are at an advanced stage at presentation, but overall and cancer-specific survival were not significantly different between unclassified and clear-cell RCC in an additional series of 38 patients. Our study of 56 cases of unclassified RCC describes the pathological features that can be applied to predict prognosis on a daily basis. In particular nuclear grade, TNM classification, tumour coagulative necrosis, tumour size, microvascular invasion and 2004 WHO histotype are independent predictors of disease-free and cancer-specific survival.
To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria.
Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron-sparing specimens. Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis.
Fifty-six cases met the histological criteria for unclassified RCC. Thirty-four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. Cox multivariate analysis showed nuclear grade (P = 0.020), stage (P < 0.001), tumour coagulative necrosis (P = 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P = 0.028) to be independent predictors of disease-free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231-25.453). Nuclear grade (P = 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P = 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P = 0.056) were independent predictors of cancer-specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329-40.622).
The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC. What's known on the subject? and What does the study add? Unclassified RCC represents 0.7-5.7% of renal tumours. Limited reported data from two series suggests that unclassified RCC is an aggressive form of RCC, mainly because most cases are at an advanced stage at presentation, but overall and cancer-specific survival were not significantly different between unclassified and clear-cell RCC in an additional series of 38 patients. Our study of 56 cases of unclassified RCC describes the pathological features that can be applied to predict prognosis on a daily basis. In particular nuclear grade, TNM classification, tumour coagulative necrosis, tumour size, microvascular invasion and 2004 WHO histotype are independent predictors of disease-free and cancer-specific survival.UNLABELLEDWhat's known on the subject? and What does the study add? Unclassified RCC represents 0.7-5.7% of renal tumours. Limited reported data from two series suggests that unclassified RCC is an aggressive form of RCC, mainly because most cases are at an advanced stage at presentation, but overall and cancer-specific survival were not significantly different between unclassified and clear-cell RCC in an additional series of 38 patients. Our study of 56 cases of unclassified RCC describes the pathological features that can be applied to predict prognosis on a daily basis. In particular nuclear grade, TNM classification, tumour coagulative necrosis, tumour size, microvascular invasion and 2004 WHO histotype are independent predictors of disease-free and cancer-specific survival.To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria.OBJECTIVETo evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria.Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron-sparing specimens. Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis.PATIENTS AND METHODSUrological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron-sparing specimens. Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis.Fifty-six cases met the histological criteria for unclassified RCC. Thirty-four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. Cox multivariate analysis showed nuclear grade (P = 0.020), stage (P < 0.001), tumour coagulative necrosis (P = 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P = 0.028) to be independent predictors of disease-free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231-25.453). Nuclear grade (P = 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P = 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P = 0.056) were independent predictors of cancer-specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329-40.622).RESULTSFifty-six cases met the histological criteria for unclassified RCC. Thirty-four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. Cox multivariate analysis showed nuclear grade (P = 0.020), stage (P < 0.001), tumour coagulative necrosis (P = 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P = 0.028) to be independent predictors of disease-free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231-25.453). Nuclear grade (P = 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P = 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P = 0.056) were independent predictors of cancer-specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329-40.622).The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC.CONCLUSIONThe prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC. Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Unclassified RCC represents 0.7–5.7% of renal tumours. Limited reported data from two series suggests that unclassified RCC is an aggressive form of RCC, mainly because most cases are at an advanced stage at presentation, but overall and cancer‐specific survival were not significantly different between unclassified and clear‐cell RCC in an additional series of 38 patients. Our study of 56 cases of unclassified RCC describes the pathological features that can be applied to predict prognosis on a daily basis. In particular nuclear grade, TNM classification, tumour coagulative necrosis, tumour size, microvascular invasion and 2004 WHO histotype are independent predictors of disease‐free and cancer‐specific survival. OBJECTIVE • To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria. PATIENTS AND METHODS • Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. • Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron‐sparing specimens. • Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis. RESULTS • Fifty‐six cases met the histological criteria for unclassified RCC. Thirty‐four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. • Cox multivariate analysis showed nuclear grade (P= 0.020), stage (P < 0.001), tumour coagulative necrosis (P= 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P= 0.028) to be independent predictors of disease‐free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231–25.453). • Nuclear grade (P= 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P= 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P= 0.056) were independent predictors of cancer‐specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329–40.622). CONCLUSION • The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC. Study Type - Therapy (case series) Level of Evidence4 What's known on the subject? and What does the study add? Unclassified RCC represents 0.7-5.7% of renal tumours. Limited reported data from two series suggests that unclassified RCC is an aggressive form of RCC, mainly because most cases are at an advanced stage at presentation, but overall and cancer-specific survival were not significantly different between unclassified and clear-cell RCC in an additional series of 38 patients. Our study of 56 cases of unclassified RCC describes the pathological features that can be applied to predict prognosis on a daily basis. In particular nuclear grade, TNM classification, tumour coagulative necrosis, tumour size, microvascular invasion and 2004 WHO histotype are independent predictors of disease-free and cancer-specific survival. OBJECTIVE * To evaluate the clinicopathological features and outcomes of 56 patients with unclassified renal cell carcinoma (RCC) meeting 2004 World Health Organization diagnostic criteria. PATIENTS AND METHODS * Urological pathology files of the participating institutions were reviewed and cases of unclassified RCC that met the inclusion criteria were retrieved. * Nuclear grade, pT status, tumour size, regional lymph node involvement, distant metastases, coagulative tumour necrosis, mucin and sarcomatoid differentiation were evaluated in radical nephrectomy or nephron-sparing specimens. * Significant factors in univariate analysis were then assessed by a multivariate analysis of independent prognostic factors using Cox proportional hazard regression analysis. RESULTS * Fifty-six cases met the histological criteria for unclassified RCC. Thirty-four (61%) cases were categorized as unrecognizable cell type (mean overall survival 47 months; median 36 months), 20 (36%) as composites of recognized types (mean overall survival 36 months; median 26 months), and two (4%) (mean survival 16 months; median 16 months) as pure sarcomatoid morphology without recognizable epithelial elements. * Cox multivariate analysis showed nuclear grade (P= 0.020), stage (P < 0.001), tumour coagulative necrosis (P= 0.018), tumour size (P < 0.001), microvascular invasion (P < 0.001) and tumour histotype (P= 0.028) to be independent predictors of disease-free survival, with tumour size being the most significant (hazard ratio [HR] 9.068, 95% confidence interval [CI] 3.231-25.453). * Nuclear grade (P= 0.026), stage (P < 0.001), tumour coagulative necrosis (P < 0.001), tumour size (P= 0.044), microvascular invasion (P < 0.001), tumour recurrence after surgery (P < 0.001) and tumour histotype (P= 0.056) were independent predictors of cancer-specific survival, with tumour recurrence after surgery being the most significant (HR 14.713, 95% CI 5.329-40.622). CONCLUSION * The prognosis of patients with unclassified RCC seems to be related to clinicopathological features known to be relevant in common forms of RCC. [PUBLICATION ABSTRACT]  | 
    
| Author | Blanca, Ana Hartmann, Arndt Algaba, Ferran Montironi, Rodolfo Scarpelli, Marina Lopez‐Beltran, Antonio Kirkali, Ziya Yorukoglu, Kutsal Cheng, Liang  | 
    
| Author_xml | – sequence: 1 givenname: Antonio surname: Lopez‐Beltran fullname: Lopez‐Beltran, Antonio – sequence: 2 givenname: Ziya surname: Kirkali fullname: Kirkali, Ziya – sequence: 3 givenname: Rodolfo surname: Montironi fullname: Montironi, Rodolfo – sequence: 4 givenname: Ana surname: Blanca fullname: Blanca, Ana – sequence: 5 givenname: Ferran surname: Algaba fullname: Algaba, Ferran – sequence: 6 givenname: Marina surname: Scarpelli fullname: Scarpelli, Marina – sequence: 7 givenname: Kutsal surname: Yorukoglu fullname: Yorukoglu, Kutsal – sequence: 8 givenname: Arndt surname: Hartmann fullname: Hartmann, Arndt – sequence: 9 givenname: Liang surname: Cheng fullname: Cheng, Liang  | 
    
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26318438$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22404824$$D View this record in MEDLINE/PubMed  | 
    
| BookMark | eNqNkF1r2zAUhsVoWT-2vzAMY7CbePo4lu1dDLqydiuF3izQO3FiS6CgSJlk0-TfT27SDrINqgtJnPO8R3rfM3Lkg9eEFIyWLK9Py5KBhBkwel9yynjJaCug3Lwip8-No6c7beUJOUtpSWkuyOo1OeEcKDQcTkk9953DlKyxui-i9uiKTru8YeysDyv8XGCur0McimCKSuZO0ukNOTbokn67P8_J_Orbz8vvs9u76x-XF7ezrgKAmWzRNIxTMI0E1ooFyNpA1VZUirpCRGpqBhzFgrUMqOALymnf17xvGRNIxTlpd3NHv8btAzqn1tGuMG4Vo2oKQy3V5FNlzxs1haEew1CbrP24065j-DXqNKiVTZM59DqMaVKDbGVdTc-8P0CXYYw5jEyJSgjJBK8z9W5PjYuV7p9_8hRnBj7sAUwdOhPRdzb94aRgDYgmc192XBdDSlEb1dkBBxv8ENG6f1i7P7TWHAz4fyp_SfdvP1inty_Wqa8388er-A27XLgg | 
    
| CODEN | BJINFO | 
    
| CitedBy_id | crossref_primary_10_1016_j_jasc_2024_11_002 crossref_primary_10_4103_iju_iju_256_24 crossref_primary_10_5858_arpa_2013_0653_RA crossref_primary_10_1016_j_abb_2020_108623 crossref_primary_10_4143_crt_2018_671 crossref_primary_10_1016_j_humpath_2020_06_007 crossref_primary_10_1097_MD_0000000000028380 crossref_primary_10_1097_PAP_0000000000000341 crossref_primary_10_1097_PCR_0000000000000215 crossref_primary_10_1097_PAS_0000000000001629 crossref_primary_10_1016_j_ctrv_2015_05_006 crossref_primary_10_1111_his_13362 crossref_primary_10_3892_mco_2016_900 crossref_primary_10_1016_j_path_2015_09_003 crossref_primary_10_1111_iju_14648 crossref_primary_10_3390_ijms24097946 crossref_primary_10_17650_1726_9776_2019_15_3_126_131 crossref_primary_10_3390_medicina59101845 crossref_primary_10_4111_kju_2014_55_10_690 crossref_primary_10_1016_j_clgc_2016_12_019 crossref_primary_10_1016_j_ajur_2024_02_005 crossref_primary_10_1016_j_hpr_2022_300611 crossref_primary_10_1038_s41598_019_52059_y  | 
    
| Cites_doi | 10.1016/j.eururo.2010.08.001 10.1309/AJCPPPR57HNJMSLZ 10.1016/j.juro.2010.12.037 10.1111/j.1464-410X.2008.07999.x 10.1016/j.juro.2007.09.076 10.1097/01.pas.0000131558.32412.40 10.1016/j.juro.2007.03.128 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G 10.1097/01.pai.0000213144.70148.8e 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R 10.1016/S0022-5347(05)64549-1 10.5858/2007-131-1234-RDAEEO 10.1159/000020370 10.1053/j.semdp.2008.07.006 10.1111/j.1442-2042.2009.02302.x 10.1111/j.1464-410X.2007.07148.x 10.1097/01.cad.0000390767.85658.83 10.1016/j.eururo.2005.11.035 10.1053/j.seminoncol.2006.06.009 10.1016/j.urology.2009.12.037  | 
    
| ContentType | Journal Article | 
    
| Copyright | 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL 2015 INIST-CNRS 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL.  | 
    
| Copyright_xml | – notice: 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL – notice: 2015 INIST-CNRS – notice: 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL.  | 
    
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7X8 ADTOC UNPAY  | 
    
| DOI | 10.1111/j.1464-410X.2012.10934.x | 
    
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Calcium & Calcified Tissue Abstracts MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE MEDLINE - Academic Calcium & Calcified Tissue Abstracts  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 1464-410X | 
    
| EndPage | 793 | 
    
| ExternalDocumentID | 10.1111/j.1464-410x.2012.10934.x 2975496401 22404824 26318438 10_1111_j_1464_410X_2012_10934_x BJU10934  | 
    
| Genre | article Research Support, Non-U.S. Gov't Journal Article  | 
    
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HF~ HGLYW HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY AIQQE CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7X8 1OB ADTOC UNPAY  | 
    
| ID | FETCH-LOGICAL-c5444-69af81204f864193b467f459506375aaa0f7142a3b1914032b020dd72d9113a03 | 
    
| IEDL.DBID | UNPAY | 
    
| ISSN | 1464-4096 1464-410X  | 
    
| IngestDate | Tue Aug 19 19:57:48 EDT 2025 Thu Oct 02 05:30:27 EDT 2025 Tue Oct 07 06:15:21 EDT 2025 Mon Jul 21 06:02:19 EDT 2025 Mon Jul 21 09:17:19 EDT 2025 Wed Oct 01 04:28:53 EDT 2025 Thu Apr 24 22:50:52 EDT 2025 Wed Jan 22 16:52:58 EST 2025  | 
    
| IsDoiOpenAccess | false | 
    
| IsOpenAccess | true | 
    
| IsPeerReviewed | true | 
    
| IsScholarly | true | 
    
| Issue | 6 | 
    
| Keywords | Kidney disease Nephrology unclassified Urinary system disease Carcinoma Prognosis pathology Malignant tumor Survival Urology Case study Anatomic pathology renal cell carcinoma Kidney cancer Classification Grawitz tumor WHO classification Cancer WHO  | 
    
| Language | English | 
    
| License | CC BY 4.0 2012 THE AUTHORS. BJU INTERNATIONAL © 2012 BJU INTERNATIONAL.  | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c5444-69af81204f864193b467f459506375aaa0f7142a3b1914032b020dd72d9113a03 | 
    
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23  | 
    
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1464-410X.2012.10934.x | 
    
| PMID | 22404824 | 
    
| PQID | 1353361327 | 
    
| PQPubID | 1026371 | 
    
| PageCount | 8 | 
    
| ParticipantIDs | unpaywall_primary_10_1111_j_1464_410x_2012_10934_x proquest_miscellaneous_1114696750 proquest_journals_1353361327 pubmed_primary_22404824 pascalfrancis_primary_26318438 crossref_citationtrail_10_1111_j_1464_410X_2012_10934_x crossref_primary_10_1111_j_1464_410X_2012_10934_x wiley_primary_10_1111_j_1464_410X_2012_10934_x_BJU10934  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | September 2012 | 
    
| PublicationDateYYYYMMDD | 2012-09-01 | 
    
| PublicationDate_xml | – month: 09 year: 2012 text: September 2012  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | Oxford, UK | 
    
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England – name: Edgecliff  | 
    
| PublicationTitle | BJU international | 
    
| PublicationTitleAlternate | BJU Int | 
    
| PublicationYear | 2012 | 
    
| Publisher | Blackwell Publishing Ltd Wiley-Blackwell Wiley Subscription Services, Inc  | 
    
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley-Blackwell – name: Wiley Subscription Services, Inc  | 
    
| References | 1997; 80 2010; 76 2007; 178 2010; 58 2000; 38 1997; 183 2011 2006; 33 2004; 28 2002; 168 2006; 49 2007; 100 2010; 134 2007; 131 2008; 25 2011; 22 2004 2008; 179 2008; 102 2011; 185 2009; 16 2007; 15 e_1_2_8_18_2 e_1_2_8_19_2 e_1_2_8_12_2 e_1_2_8_23_2 e_1_2_8_13_2 e_1_2_8_14_2 e_1_2_8_15_2 e_1_2_8_9_2 Shen SS (e_1_2_8_16_2) 2007; 131 e_1_2_8_2_2 e_1_2_8_3_2 Eble JN (e_1_2_8_4_2) 2004 e_1_2_8_6_2 e_1_2_8_5_2 e_1_2_8_8_2 e_1_2_8_7_2 e_1_2_8_20_2 e_1_2_8_10_2 e_1_2_8_21_2 e_1_2_8_11_2 e_1_2_8_22_2 Algaba F (e_1_2_8_17_2) 2011  | 
    
| References_xml | – volume: 80 start-page: 987 year: 1997 end-page: 9 article-title: Classification of renal cell carcinoma: workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) publication-title: Cancer – year: 2011 – volume: 178 start-page: 425 year: 2007 end-page: 8 article-title: Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma publication-title: J Urol – volume: 16 start-page: 432 year: 2009 end-page: 43 article-title: 2009 update on the classification of renal epithelial tumors in adults publication-title: Int J Urol – volume: 185 start-page: 1611 year: 2011 end-page: 4 article-title: Prognostic factors for renal cell carcinoma with bone metastasis: who are the long‐term survivors? publication-title: J Urol – volume: 102 start-page: 1381 year: 2008 end-page: 4 article-title: Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC publication-title: BJU Int – volume: 183 start-page: 131 year: 1997 end-page: 3 article-title: The Heidelberg classification of renal cell tumours publication-title: J Pathol – volume: 58 start-page: 655 year: 2010 end-page: 68 article-title: Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors publication-title: Eur Urol – volume: 38 start-page: 728 year: 2000 end-page: 33 article-title: Prognostic significance of microvascular invasion in localized renal cell carcinoma publication-title: Eur Urol – volume: 15 start-page: 310 year: 2007 end-page: 5 article-title: Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic Implications publication-title: Appl Immunohistochem Mol Morphol – year: 2004 – volume: 168 start-page: 950 year: 2002 end-page: 5 article-title: Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype publication-title: J Urol – volume: 33 start-page: 534 year: 2006 end-page: 43 article-title: The pathology of renal epithelial neoplasms publication-title: Semin Oncol – volume: 49 start-page: 798 year: 2006 end-page: 805 article-title: 2004 WHO classification of the renal tumors of the adults publication-title: Eur Urol – volume: 76 start-page: 580 year: 2010 end-page: 6 article-title: Unclassified renal cell carcinoma: impact on survival following nephrectomy publication-title: Urology – volume: 131 start-page: 1234 year: 2007 end-page: 43 article-title: Recently Described and Emphasized Entities of Renal Neoplasms publication-title: Arch Pathol Lab Med – volume: 28 start-page: 1117 year: 2004 end-page: 32 article-title: Morphologic and molecular characterization of renal cell carcinoma in children and young adults publication-title: Am J Surg Pathol – volume: 134 start-page: 873 year: 2010 end-page: 9 article-title: Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade publication-title: Am J Clin Pathol – volume: 25 start-page: 232 year: 2008 end-page: 44 article-title: Targeted therapies and biological modifiers in urologic tumors: pathobiology and clinical implications publication-title: Semin Diagn Pathol – volume: 100 start-page: 802 year: 2007 end-page: 8 article-title: Unclassified renal cell carcinoma: an analysis of 85 cases publication-title: BJU Int – volume: 22 start-page: S9 issue: 1 year: 2011 end-page: S14 article-title: Non‐clear cell advanced kidney cancer: is there a gold standard? publication-title: Anticancer Drugs – volume: 179 start-page: 439 year: 2008 end-page: 43 article-title: The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification publication-title: J Urol – ident: e_1_2_8_18_2 doi: 10.1016/j.eururo.2010.08.001 – ident: e_1_2_8_22_2 doi: 10.1309/AJCPPPR57HNJMSLZ – ident: e_1_2_8_14_2 doi: 10.1016/j.juro.2010.12.037 – ident: e_1_2_8_23_2 doi: 10.1111/j.1464-410X.2008.07999.x – volume-title: Pathology and Genetics. Tumors of the Urinary System and Male Genital Organs year: 2004 ident: e_1_2_8_4_2 – ident: e_1_2_8_6_2 doi: 10.1016/j.juro.2007.09.076 – ident: e_1_2_8_11_2 doi: 10.1097/01.pas.0000131558.32412.40 – ident: e_1_2_8_20_2 doi: 10.1016/j.juro.2007.03.128 – ident: e_1_2_8_2_2 doi: 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G – ident: e_1_2_8_10_2 doi: 10.1097/01.pai.0000213144.70148.8e – ident: e_1_2_8_3_2 doi: 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R – ident: e_1_2_8_7_2 doi: 10.1016/S0022-5347(05)64549-1 – volume: 131 start-page: 1234 year: 2007 ident: e_1_2_8_16_2 article-title: Recently Described and Emphasized Entities of Renal Neoplasms publication-title: Arch Pathol Lab Med doi: 10.5858/2007-131-1234-RDAEEO – volume-title: ICUD‐EAU International Consultation on Kidney Cancer 2011: Pathology year: 2011 ident: e_1_2_8_17_2 – ident: e_1_2_8_19_2 doi: 10.1159/000020370 – ident: e_1_2_8_12_2 doi: 10.1053/j.semdp.2008.07.006 – ident: e_1_2_8_13_2 doi: 10.1111/j.1442-2042.2009.02302.x – ident: e_1_2_8_8_2 doi: 10.1111/j.1464-410X.2007.07148.x – ident: e_1_2_8_21_2 doi: 10.1097/01.cad.0000390767.85658.83 – ident: e_1_2_8_9_2 doi: 10.1016/j.eururo.2005.11.035 – ident: e_1_2_8_5_2 doi: 10.1053/j.seminoncol.2006.06.009 – ident: e_1_2_8_15_2 doi: 10.1016/j.urology.2009.12.037  | 
    
| SSID | ssj0014665 | 
    
| Score | 2.2228117 | 
    
| Snippet | Study Type – Therapy (case series)
Level of Evidence 4
What's known on the subject? and What does the study add?
Unclassified RCC represents 0.7–5.7% of renal... What's known on the subject? and What does the study add? Unclassified RCC represents 0.7-5.7% of renal tumours. Limited reported data from two series suggests... Study Type - Therapy (case series) Level of Evidence4 What's known on the subject? and What does the study add? Unclassified RCC represents 0.7-5.7% of renal...  | 
    
| SourceID | unpaywall proquest pubmed pascalfrancis crossref wiley  | 
    
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 786 | 
    
| SubjectTerms | Adult Aged Aged, 80 and over Biological and medical sciences Carcinoma, Renal Cell - classification Carcinoma, Renal Cell - pathology Confidence intervals Female Humans Kidney Neoplasms - classification Kidney Neoplasms - pathology Kidneys Male Medical research Medical sciences Middle Aged Multivariate analysis Nephrology. Urinary tract diseases pathology prognosis renal cell carcinoma Retrospective Studies survival Tumors of the urinary system unclassified WHO classification  | 
    
| SummonAdditionalLinks | – databaseName: Wiley Online Library - Core collection (SURFmarket) dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9wwDBejD_tgrPtutq5ksNcc-VDsZG_baCmF7mHs4N6M7Yth9Jo7mjvW7a-vZOcycpRRxiAPIbYSW5bsn2xFAvhQ1SJzJAmJrRuTIBYmqYwQSVnZ1MqsKYXfzDn_Kk6neDYrZ73_E_8LE-JDDBturBl-vmYF16bbVXJMMEtn7KGV-8BIOGE8mRXCW1ffhkhSVNVnlQwkBNvHTj23vmi0Uj1e6Y6Y5kK2i9vg6CN4sGlX-tdPvViMka5fqk724WLbyeChcjHZrM3E_t6J__h_uPAUnvSINv4URPAZ3Gva53D_vD-zfwFy2lqG6D8cod34quHKfFwQW05j1C4v9cdYx-HsIl66uBRU0jXdS5ieHH__cpr06RoSWyJiImrtCC6k6CqBhAsNzcEOy7okFCRLrXXqZIa5LgzHlEuL3BBUnc9lPqcJt9Bp8Qr22mXbHEBcabLbtBCOg8ejNbWWdDk0tq4biXUEcjs0yvaxzDmlxkKNbBpUzBfFfFGeL-o6gmygXIV4HnegORqN_kCYi4LT5VQRHG7FQfVTQKc4oUhBYCmXEbwfikl5mcW6bZabjj-LoiabLY3gdRCjPy8nrIVVjhHkg1z9pcnXO02WXmru3Ef1-Wzqb9_8M-VbeMjPgwPeIeytrzbNO0Jsa3PkdfEGvrIpgA priority: 102 providerName: Wiley-Blackwell  | 
    
| Title | Unclassified renal cell carcinoma: a report of 56 cases | 
    
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2012.10934.x https://www.ncbi.nlm.nih.gov/pubmed/22404824 https://www.proquest.com/docview/1353361327 https://www.proquest.com/docview/1114696750 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1464-410X.2012.10934.x  | 
    
| UnpaywallVersion | publishedVersion | 
    
| Volume | 110 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1464-410X dateEnd: 20241102 omitProxy: true ssIdentifier: ssj0014665 issn: 1464-410X databaseCode: ABDBF dateStart: 19990101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1464-410X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014665 issn: 1464-410X databaseCode: DIK dateStart: 19990101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1464-410X databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1464-410X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014665 providerName: Wiley-Blackwell  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ri9QwEB-OPfCB-H5Uz6WCX7u26TRp_HaKx3Fwi4iF9VNJsg2Ia7tcd3H1r3fSdKs9RA4R-iFt3tPJ5JdkMgPwMpc8scQJkZGVjhBTHeWa8yjLTWxEUmW828w5n_PTAs8W2eIA5vu7MN4-xLDh5kZGJ6_dAF8vrZfzr37Tx0GOESbxwmlpsc44Es4IUx7yjLD5BA6L-fvjT_6KESWMJR_ClGms2tN_3Y2KGs1Xt9aqJdJZ7_PiT6D0Jlzf1mv1_ZtarcZ4t5uwTu5As--q11P5Mttu9Mz8uGQF8v_R4i7c7rFteOyZ8R4cVPV9uHben94_AFHUxoH1z5Zwb3hRucTu4CA0zqFR3XxVr0MV-lOMsLFhximmrdqHUJy8-_j2NOodN0QmQ8SIS2UJOMRoc46EEDVJY4uZzAgPiUwpFVuRIFOpdtbl4pRpAq3LpWBLEr2pitNHMKmbunoCYa5oBac4t86MPBotlaDHojZSVgJlAGL_e0rTWzV3zjVW5Wh1g6WjS-noUnZ0KXcBJEPOtbfscYU80xEHDBkZT53jnDyAoz1LlL0waEvnWiQl2MREAC-GaBrGjsSqrppt66pFLmn1Fgfw2LPSr8IJdWHOMAA28NZfmry71GTRcc6V-1i-OSu64NN_qe4Z3HCvXgvvCCabi231nGDbRk9pwfKBTfsR-RNrVy8_ | 
    
| linkProvider | Unpaywall | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_kBE8Rvz-q51nB1y79mCaNb34d63l7D3IL-xaSbAPi2l2uu3j61zvTditdDjlE6ENpMm0ymZn8kkxnAF4XSiSeJCFyqrQRYmajwgoR5YWLnUzKXDSbOZNTMZ7i8SyfdemA-F-YNj5Ev-HGmtHYa1Zw3pDe1XKMMIln7KKVNpGRcESA8jo9j1nEP3zpY0lR3SavZEtDwH3o1nPpmwZz1e2VqYltvs13cRkgvQX7m2plfv4wi8UQ6zaT1dFdWGy72fqofBtt1nbkfu1EgPxPfLgHdzpQG75tpfA-XCurB3Bj0h3bPwQ5rRyj9K-eAG94XnJlPjEIHWcyqpbfzZvQhO3xRbj0YS6opC7rRzA9-nj2fhx1GRsilyNiJJTxhBhi9IVAgoaWzLDHXOUEhGRujIm9TDA1meWwcnGWWkKr87lM52RzMxNnj2GvWlblUwgLQ0s3I4Tn-PHorDKSLo_WKVVKVAHI7dho14Uz56waCz1Y1qBmvmjmi274oi8CSHrKVRvS4wo0h4Ph7wlTkXHGnCKAg6086M4K1JpzimSEl1IZwKu-mPSXWWyqcrmp-bMoFC3b4gCetHL05-UEt7BIMYC0F6y_NPlip8myEZsr91G_O542t8_-mfIl7I_PJif65NPp5-dwk-u0_ngHsLc-35QvCMCt7WGjmL8Bg4wtoQ | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_khNND_D6tnmcFX7v0Y5q0vqnncp7eIeLCvoUkm4C4dpfrLp7-9c603UqXQw4R-lBIJk0mM5NfkukMwMuiFIknSYhs6UyEmJmoMEJEeWFjKxOXi-Yw5_RMHE_wZJpPu3RA_C9MGx-iP3BjzWjsNSu4W878tpZjhEk8ZRettImMhCMClNcxLwv27zv63MeSorpNXsmWhoD70K3n0pYGa9Wtpa6Jbb7Nd3EZIN2DG-tqqX_-0PP5EOs2i9X4Dsw3w2x9VL6N1iszsr-2IkD-Jz7chdsdqA1ft1J4D6656j7snnbX9g9ATirLKP2rJ8AbnjuuzDcGoeVMRtXiu34V6rC9vggXPswFldSufgiT8bsvb4-jLmNDZHNEjESpPSGGGH0hkKChITPsaTJyAkIy11rHXiaY6sxwWLk4Sw2h1dlMpjOyuZmOs33YqRaVewxhoWnrpoXwHD8erSm1pMejsWXpJJYByM3cKNuFM-esGnM12NagYr4o5otq-KIuAkh6ymUb0uMKNIeD6e8JU5FxxpwigIONPKjOCtSKc4pkhJdSGcCLvpj0l1msK7dY1_xZFCVt2-IAHrVy9KdxgltYpBhA2gvWX7p8sdVl2YjNlceo3pxMmtcn_0z5HHY_HY3Vx_dnH57CTa7SuuMdwM7qfO2eEX5bmcNGL38D6jktJQ | 
    
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB-OPVAP8fujeh4VfO3aj2nS-HaKx3Fwiw8W1qeQZBs4XNvlusut_vVOmm61h8ghQh_S5ns6mfySTGYA3hSCJZY4ITKi0hFipqNCMxblhYkNT6qcdZs55zN2WuLZPJ_vwWx3F8bbhxg23NzI6OS1G-CrhfVy_u1v-jjIMMIknjstrbQzjoRTwpT7LCdsPoH9cvbp-Iu_YkQJY8GGMGUaq_b0X7ejokbz1d2Vaol01vu8-BMoPYDbm3qlvl-p5XKMd7sJ6-Q-NLuuej2Vr9PNWk_Nj2tWIP8fLR7AvR7bhseeGR_CXlU_glvn_en9Y-BlbRxYv7CEe8PLyiV2BwehcQ6N6uabeheq0J9ihI0Nc0YxbdU-gfLk4-cPp1HvuCEyOSJGTChLwCFGWzAkhKhJGlvMRU54iOdKqdjyBFOVaWddLs5STaB1seDpgkRvpuLsKUzqpq6eQ1goWsEpxqwzI49GC8XpsaiNEBVHEQDf_R5peqvmzrnGUo5WNygdXaSji-zoIrcBJEPOlbfscYM8RyMOGDKmLHOOc4oADncsIXth0ErnWiQj2JTyAF4P0TSMHYlVXTWb1lWLTNDqLQ7gmWelX4UT6sIixQDSgbf-0uTttSbzjnNu3Ef5_qzsgi_-pbqXcMe9ei28Q5isLzfVK4Jta33Uj8WfVbouVg | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unclassified+renal+cell+carcinoma%3A+a+report+of+56+cases&rft.jtitle=BJU+international&rft.au=LOPEZ-BELTRAN%2C+Antonio&rft.au=KIRKALI%2C+Ziya&rft.au=MONTIRONI%2C+Rodolfo&rft.au=BLANCA%2C+Ana&rft.date=2012-09-01&rft.pub=Wiley-Blackwell&rft.issn=1464-4096&rft.volume=110&rft.issue=6&rft.spage=786&rft.epage=793&rft_id=info:doi/10.1111%2Fj.1464-410X.2012.10934.x&rft.externalDBID=n%2Fa&rft.externalDocID=26318438 | 
    
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon | 
    
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon | 
    
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon |